New biomarker study aims to improve outcomes for infants with rare heart condition
NCT ID NCT03404258
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study measures certain substances in the blood (biomarkers) of infants with a rare heart defect called single-ventricle. The goal is to understand how these biomarkers relate to lung blood flow before and after a specific heart surgery (superior cavo-pulmonary anastomosis). Researchers will compare results from healthy infants and those with the condition to find new ways to predict and treat complications. About 50 infants up to 2 years old will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOTHELIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital Colorado
Denver, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dopamine may unclog lymphatic system in rare heart complication
- Can a common diuretic protect the liver and heart in children born with one heart chamber?
- Blueberry study: your gut bugs may control how you absorb superfood
- Special baby formula may boost growth in heart defect infants
- Ultrasound may help pick better breathing tubes for kids with heart defects
- Toronto study links Mom's gut bugs to Baby's future health